SCHEMBL1969639

SCHEMBL1969639

C#CCCCCCCCCCCCC(CC(O)CO)OC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 5/20 0.58
CYP3A4 P08684 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MAPT P10636 3/20 0.55
ALDH1A1 P00352 3/20 0.55
MEN1 O00255 1/20 0.55
TP53 P04637 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 1/20 0.55
PDCD4 Q53EL6 2/20 0.38
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PRKCA P17252 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TRPV1 Q8NER1 1/20 0.32
GLS2 Q9UI32 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12326383 0.89 USP2 (0.55) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL1535195 0.82 USP2 (0.49) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
Avocadyne SCHEMBL30697473 0.79 USP2 (0.81) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL1970909 0.77 USP2 (0.55) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL1535232 0.76 USP2 (0.42) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL1535254 0.76 USP2 (0.42) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL2152008 0.75 USP2 (0.46) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
SCHEMBL1535295 0.75 USP2 (0.50) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
Avocadyne SCHEMBL18730915 0.74 USP2 (1.00) USP2CYP3A4SMN1; SMN2MAPTALDH1A1
Avocadyne SCHEMBL1970908 0.74 USP2 (1.00) USP2CYP3A4SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110250154-A1 COSMETIC COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOLS AND DERIVATIVES AND USES THEREOF POLYOL BIOTECH LTD (IL) 2011-10-13 US claimed
US-20110217251-A1 THERAPEUTIC COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND USES THEREOF MERETZKI SHAI 2011-09-08 US claimed
EP-2340089-A2 COSMETIC COMPOSITIONS COMPRISING POLYHYDROXYLATED FATTY ALCOHOLS AND DERIVATIVES AND USES THEREOF Polyol Biotech Ltd. (IL) 2011-07-06 EP claimed
EP-2334293-A2 COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND THE THERAPEUTIC USES Meretzki, Shai (IL) 2011-06-22 EP claimed
WO-2010026595-A2 COSMETIC COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOLS AND DERIVATIVES AND USES THEREOF POLYOL BIOTECH LTD. (IL) 2010-03-11 WO claimed
WO-2010026596-A2 COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND THE THERAPEUTIC USES MERETZKI SHAI (IL) 2010-03-11 WO claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN disclosed
US-20110250154-A1 COSMETIC COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOLS AND DERIVATIVES AND USES THEREOF POLYOL BIOTECH LTD (IL) 2011-10-13 US disclosed
US-20110217251-A1 THERAPEUTIC COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND USES THEREOF MERETZKI SHAI 2011-09-08 US disclosed
EP-2334293-A2 COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND THE THERAPEUTIC USES Meretzki, Shai (IL) 2011-06-22 EP disclosed
WO-2010026596-A2 COMPOSITIONS COMPRISING POLYHYDROXYLTATE FATTY ALCOHOL DERIVATIVES AND THE THERAPEUTIC USES MERETZKI SHAI (IL) 2010-03-11 WO disclosed